Hodgkin lymphoma a comprehensive update on diagnostics and clinics /

Por Engert, Andreas., Horning, Sandra J.
Publicado em 2011

A compiler generator /

Por McKeeman, William M., Horning, James J., Wortman, David B.
Publicado em 1970

Immunoglobulin G Fc Receptor FcγRIIIa 158 V/F Polymorphism Correlates With Rituximab-Induced Neutropenia After Autologous Transplantation in Patients With Non-Hodgkin's Lymphoma

Por Weng, Wen-Kai, Negrin, Robert S., Lavori, Philip, Horning, Sandra J.
Publicado em 2010

A compiler generator.

Por McKeeman, William M., Horning, James J., Wortman, David B.
Publicado em C1970

Role of D-amino acid oxidase in the production of kynurenine pathway metabolites from D-tryptophan in mice

Por Notarangelo, Francesca M., Wang, Xiao-Dan, Horning, Kyle J., Schwarcz, Robert
Publicado no J Neurochem (2016)

Localization of predisposition to Hodgkin disease in the HLA class II region.

Por Klitz, W., Aldrich, C. L., Fildes, N., Horning, S. J., Begovich, A. B.
Publicado em 1994

Long-Term Results Of Autologous Hematopoietic Cell Transplantation For Peripheral T Cell Lymphoma: The Stanford Experience

Por Chen, Andy I., McMillan, Alex, Negrin, Robert S., Horning, Sandra J., Laport, Ginna G.
Publicado em 2008

Clonal T-cell populations in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma.

Por Weiss, L. M., Strickler, J. G., Dorfman, R. F., Horning, S. J., Warnke, R. A., Sklar, J.
Publicado em 1986

Sigma-1 receptor ligands inhibit catecholamine secretion from adrenal chromaffin cells due to block of nicotinic acetylcholine receptors

Por Brindley, Rebecca L., Bauer, Mary Beth, Hartley, Nolan D., Horning, Kyle J., Currie, Kevin P.M.
Publicado no J Neurochem (2017)

Dynamic CD8 T-Cell Responses to Tumor-Associated Epstein-Barr Virus Antigens in Patients With Epstein-Barr Virus-Negative Hodgkin’s Disease

Por Kohrt, Holbrook, Johannsen, Alexandre, Hoppe, Richard, Horning, Sandra J., Rosenberg, Saul A., Advani, Ranjana, Lee, Peter P.
Publicado no Oncol Res (2009)

Stage I-IIA Non-Bulky Hodgkin Lymphoma. Is Further Distinction Based on Prognostic Factors Useful? The Stanford Experience

Por Advani, Ranjana H., Hoppe, Richard T, Maeda, Lauren S., Baer, David M., Mason, Joseph, Rosenberg, Saul A, Horning, Sandra J
Publicado em 2010

Efficacy of abbreviated Stanford V chemotherapy and involved-field radiotherapy in early-stage Hodgkin lymphoma: mature results of the G4 trial(†)

Por Advani, R. H., Hoppe, R. T., Baer, D., Mason, J., Warnke, R., Allen, J., Daadi, S., Rosenberg, S. A., Horning, S. J.
Publicado em 2013

Risk of Therapy-Related Secondary Leukemia in Hodgkin Lymphoma: The Stanford University Experience Over Three Generations of Clinical Trials

Por Koontz, Michael Zach, Horning, Sandra J., Balise, Raymond, Greenberg, Peter L., Rosenberg, Saul A., Hoppe, Richard T., Advani, Ranjana H.
Publicado em 2013

Major histocompatibility complex class I and class II antigen expression in diffuse large cell and large cell immunoblastic lymphomas. Absence of a correlation between antigen expr...

Por Medeiros, L. J., Gelb, A. B., Wolfson, K., Doggett, R., McGregor, B., Cox, R. S., Horning, S. J., Warnke, R. A.
Publicado em 1993

Cardiac toxicity associated with bevacizumab (Avastin) in combination with CHOP chemotherapy for peripheral T cell lymphoma in ECOG 2404 trial

Por Advani, Ranjana H., Hong, Fangxin, Horning, Sandra J., Kahl, Brad S., Manola, Judith, Swinnen, Lode J., Habermann, Thomas M., Ganjoo, Kristen
Publicado em 2011

Interim positron emission tomography scans in diffuse large B-cell lymphoma: an independent expert nuclear medicine evaluation of the Eastern Cooperative Oncology Group E3404 study

Por Horning, Sandra J., Juweid, Malik E., Schöder, Heiko, Wiseman, Gregory, McMillan, Alex, Swinnen, Lode J., Advani, Ranjana, Gascoyne, Randy, Quon, Andrew
Publicado em 2010

Evaluation of kynurenine pathway metabolism in Toxoplasma gondii-infected mice: Implications for schizophrenia

Por Notarangelo, F. M., Wilson, E. H., Horning, K. J., Thomas, M. A. R., Harris, T. H., Fang, Q., Hunter, C. A., Schwarcz, R.
Publicado em 2013

Bevacizumab and CHOP (A-CHOP) in Combination for Patients with Peripheral T-Cell or Natural Killer Cell Neoplasms: An Eastern Cooperative Group Study (E2404)

Por Ganjoo, Kristen, Hong, Fangxin, Horning, Sandra J., Gascoyne, Randy D., Natkunam, Yasodha, Swinnen, Lode J., Habermann, Thomas M., Kahl, Brad S., Advani, Ranjana H.
Publicado em 2013

A Phase II Trial of R-CHOP Followed by Radioimmunotherapy for Early Stage (Stages I/II) Diffuse Large B-Cell Non-Hodgkin Lymphoma: ECOG3402

Por Witzig, Thomas E., Hong, Fangxin, Micallef, Ivana N., Gascoyne, Randy D., Dogan, Ahmet, Wagner, Henry, Kahl, Brad S., Advani, Ranjana H., Horning, Sandra J.
Publicado no Br J Haematol (2015)

Fc gamma receptor 3A and 2A polymorphisms do not predict response to rituximab in follicular lymphoma

Por Kenkre, Vaishalee P., Hong, Fangxin, Cerhan, James R., Lewis, Marcia, Sullivan, Leslie, Williams, Michael E., Gascoyne, Randy D., Horning, Sandra J., Kahl, Brad S.
Publicado no Clin Cancer Res (2015)